anti-Calcium Independent Phospholipase A2 (PNPLA2) Antikörper

PNPLA2 encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Zusätzlich bieten wir Ihnen Calcium Independent Phospholipase A2 Kits (7) und und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
PNPLA2 57104 Q96AD5
PNPLA2    
PNPLA2    
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Calcium Independent Phospholipase A2 Antikörper auf antikoerper-online.de

Showing 5 out of 5 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Human Kaninchen Unkonjugiert IF/ICC, IHC, IP, WB Western blot analysis of (1) Human U87-MG Cells and (2) Mouse Testis Tissue. Western blot analysis of recombinant Human iPLA2. 100 μg Anmelden zum Anzeigen 11 bis 18 Tage
$412.19
Details
Maus Kaninchen Unkonjugiert IF/ICC, IHC, IP, WB Western blot analysis of Rat Testis lysate, using Mouse iPLA2 Antibody (1 µg/ml) and HRP-conjugated Goat Anti-Rabbit antibody ( Western blot analysis of the recombinant protein. 100 μg Anmelden zum Anzeigen 11 bis 18 Tage
$426.40
Details
Ratte Kaninchen Unkonjugiert IF/ICC, IHC, IP, WB Western blot analysis of the recombinant protein. IHC-P analysis of Liver tissue, with DAB staining. 100 μg Anmelden zum Anzeigen 11 bis 18 Tage
$440.62
Details
Human Maus Unkonjugiert IF/ICC, IHC, IP, WB   200 μg Anmelden zum Anzeigen 11 bis 18 Tage
$412.19
Details
Ratte Maus Unkonjugiert IF/ICC, IHC, IP, WB   200 μg Anmelden zum Anzeigen 11 bis 18 Tage
$440.62
Details

Weitere Antikörper gegen Calcium Independent Phospholipase A2 Interaktionspartner

Human Calcium Independent Phospholipase A2 (PNPLA2) Interaktionspartner

  1. Evidence for a previously uncovered tumor-suppressor function of ATGL in hepatocellular carcinoma, with the outlined molecular mechanisms shedding light on new potential targets for anticancer therapy.

  2. No difference in the genotype frequency of rs7925131 or rs7942159 in PNPLA2 between the normal free fatty acids (FFA) group and the high FFA group in a Chinese Han population.

  3. Non-cardiac ATGL-mediated modulation of the cardiac lipidome may play an important role in the pathogenesis of chronic heart failure.

  4. Although we found evidence for moderate association between PNPLA2 tagSNPs and anthropometric and metabolic parameters in our cohort, no evidence for association between polymorphisms in the PNPLA2 gene and the presence and severity of non-alcoholic fatty liver disease was identified.

  5. Study reports the derivation of iPSCs from fibroblasts of two Neutral Lipid Storage Disease with Myopathy (NLSDM)patients carrying different ATGL mutations. These iPSCs exhibited defects in neutral lipid metabolism similar to those of NLSDM fibroblasts. NLSDM-iPSCs were able to undergo directed differentiation into cardiomyocytes.

  6. Thus, ATGL in leucocytes may be an important biomarker for the diagnosis of TGCV and our assay may provide insights into pathophysiology and elucidate the underlying mechanism of TGCV and related disorders.

  7. The ATGL gene was frequently deleted in various forms of human cancers and was associated with poor prognosis.

  8. a Snail1-ATGL axis that regulates adipose lipolysis and fatty acid release, is reported.

  9. ABHD5 possesses a PNPLA2-independent function in regulating autophagy and tumorigenesis.

  10. Oxidative stress decreased the levels of PNPLA2 transcripts with no effect on ALOX5 expression. Exogenous additions of P1 peptide or overexpression of the PNPLA2 gene decreased both LTB4 levels and death of RPE cells undergoing oxidative stress.

  11. Results suggest that increased adipose triglyceride lipase (ATGL) expression is associated with increased adiposity and stromal proliferation in patients with pancreatic ductal adenocarcinoma (PDAC).

  12. A missense mutation in PNPLA2 is the rare cause of severe dilated cardiomyopathy secondary to neutral lipid storage disease.

  13. A novel deletion was identified in PNPLA2 protein from a patient with complete deficiency of adipose triglyceride lipase.

  14. Rab32 controls intracellular lipid accumulation through inducing lipolysis via enhancing ATGL expression indirectly.

  15. Data indicate that a tumor suppressor mechanism by which G0/G1 switch gene 2 product (G0S2) directly inhibits activity of a key intracellular adipose triglyceride lipase (ATGL).

  16. Authors show that rat ATGL, coactivated by rat CGI-58, efficiently hydrolyzes triglycerides and retinyl ester.

  17. PNPLA2 mutations were associated with an extended phenotype, including brain involvement in cases of neutral lipid-storage disease with myopathy.

  18. Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase.

  19. ANGPTL8 is a stress-response protein that down-regulates expression of ATGL.

  20. Study reports the clinical and genetic findings of a neutral lipid storage disease with myopathy family of Italian origin with 3 affected siblings. to highlight the effect that different gene mutations may have on ATGL lipase activity, authors performed a functional characterization of the novel PNPLA2 missense mutations identified in their patients

Calcium Independent Phospholipase A2 (PNPLA2) Antigen-Profil

Protein Überblick

This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy.

Genbezeichner und Symbole assoziert mit PNPLA2

  • patatin like phospholipase domain containing 2 (PNPLA2) Antikörper
  • 1110001C14Rik Antikörper
  • ATGL Antikörper
  • iPLA2zeta Antikörper
  • PEDF-R Antikörper
  • TTS-2.2 Antikörper
  • TTS2 Antikörper

Bezeichner auf Proteinebene für PNPLA2

IPLA2-zeta , TTS2.2 , adipose triglyceride lipase , calcium-independent phospholipase A2 , desnutrin , patatin-like phospholipase domain containing protein 2 , patatin-like phospholipase domain-containing protein 2 , pigment epithelium-derived factor , transport-secretion protein 2.2 , triglyceride hydrolase

GENE ID SPEZIES
57104 Homo sapiens
Ausgewählte Anbieter für anti-Calcium Independent Phospholipase A2 (PNPLA2) Antikörper
Haben Sie etwas anderes gesucht?